Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Event, Nonprofit, Contest

The 29th Annual 2024 New York Sohn Investment Conference to Convene Top Hedge Fund Leaders and Global Investors on April 3 in New York City


The Sohn Conference Foundation, an organization dedicated to the treatment and cure of pediatric cancer and other childhood diseases, is pleased to announce the 29th annual New York Sohn Investment Conference, in partnership with CNBC, on April 3, 2024. The conference will be held at Jazz at Lincoln Center's Frederick P. Rose Hall in New York City, and will convene some of the world's top hedge fund and alternative investors, featuring dynamic on-stage presentations, fireside chats, networking and interactive programming.

The 2024 New York Sohn Investment Conference will benefit The Rockefeller University, whose acquisition of a high-performance supercomputer has been pivotal to scientists at the forefront of discovery. In 2020 and 2021, The Foundation provided funding for the University's development of a novel monoclonal antibody therapy for COVID-19.

"Sohn New York provides an incredible opportunity to convene some of the most influential investors across asset classes, united by a shared commitment to supporting groundbreaking research and initiatives that are tackling today's public health priorities," said Evan Sohn, Vice President and Co-Founder of the Sohn Conference Foundation. "We are honored to support Rockefeller University and are thankful to our generous contributors who will help make this year's conference the most successful yet."

Confirmed speakers include:

Next Wave Sohn offers leaders of innovative new hedge fund launches the chance to present their best investment ideas during a dedicated portion of the day. Moderating a panel on short selling will be Carter Simonds, Managing Partner, Four Pines. Other Next Wave speakers include:

In addition to the main conference program, emerging leaders in the global financial industry are being called upon to identify a timely and actionable investment idea for the Sohn Idea Contest. The winner will have the opportunity to present their idea at the event in front of an elite audience and a panel of judges, which includes Bill Ackman, Mala Gaonkar, Brad Gerstner, and Jonathan Pollock. If you think you have the next big investment idea, apply by Feb. 29 here: https://webportalapp.com/sp/login/sohnideacontest2024.

For more information on the New York Sohn Investment Conference, including purchasing tickets, the current agenda and confirmed speakers to date, please visit: https://www.sohnconference.org/sohn2024.

If you are a member of the press interested in covering this event, please contact: [email protected]

About the Sohn Conference Foundation

The Sohn Conference Foundation brings together the most successful investors from across the country and around the world, to connect and learn through our conferences, all of which support children's health programs and life outcomes. Sohn New York has served as the anchor conference and inspiration for Sohn Conferences around the world, including in San Francisco, London, Hong Kong, Tel Aviv, Monaco and Sydney.

The Sohn Conference Foundation honors the memory of Ira Sohn, a talented Wall Street professional whose life was cut short when he passed away from cancer at the age of 29. Ira's friends and family founded The Sohn Conference Foundation in New York City in 1995. Since then, investment leaders from across the globe have been inspired to launch partner Sohn conferences and unite the financial community to support a number of charitable causes. To date, The Sohn Conference series has raised more than $100 million.

To learn more about the Sohn Conference Foundation, please visit: www.sohnconference.org.


These press releases may also interest you

at 10:05
Results from the DESTINY-Breast12 phase 3b/4 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated substantial overall and intracranial clinical activity in a large cohort of patients with HER2 positive metastatic breast cancer who have...

at 10:05
Results from the DESTINY-Breast12 Phase IIIb/IV trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated substantial overall and intracranial clinical activity in a large cohort of patients with HER2-positive metastatic breast cancer...

at 10:00
Sylvan Learning of Johnston & Des Moines is proud to announce that it has been awarded a $450,000 grant funded by the State of Iowa to provide accelerated after-school tutoring to students in Des Moines Public Schools. The grant, part of Iowa's...

at 09:25
Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to...

at 09:20
For most students attending college, a reliable internet connection is something they can count on. For students attending Claflin University, a small Historically Black College and University (HBCU) located in rural Orangeburg, South Carolina,...

at 09:00
Amgen  today announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking place Sept. 13-17 in Barcelona. The abstracts showcase data from...



News published on and distributed by: